nodes	percent_of_prediction	percent_of_DWPC	metapath
Doxorubicin—bone cancer—ocular cancer	0.166	0.301	CtDrD
Doxorubicin—muscle cancer—ocular cancer	0.147	0.266	CtDrD
Doxorubicin—peripheral nervous system neoplasm—ocular cancer	0.122	0.22	CtDrD
Doxorubicin—sarcoma—ocular cancer	0.117	0.212	CtDrD
Doxorubicin—ABCC6—Dactinomycin—ocular cancer	0.113	0.326	CbGbCtD
Doxorubicin—NQO1—Carboplatin—ocular cancer	0.0911	0.262	CbGbCtD
Doxorubicin—XDH—Carboplatin—ocular cancer	0.0476	0.137	CbGbCtD
Doxorubicin—ABCC1—Dactinomycin—ocular cancer	0.0335	0.0962	CbGbCtD
Doxorubicin—ABCG2—Dactinomycin—ocular cancer	0.0224	0.0644	CbGbCtD
Doxorubicin—ABCC2—Carboplatin—ocular cancer	0.0166	0.0478	CbGbCtD
Doxorubicin—ABCG2—Carboplatin—ocular cancer	0.015	0.0433	CbGbCtD
Doxorubicin—ABCB1—Dactinomycin—ocular cancer	0.00807	0.0232	CbGbCtD
Doxorubicin—Radiation injury—Dactinomycin—ocular cancer	0.00306	0.109	CcSEcCtD
Doxorubicin—Radiation recall reaction (dermatologic)—Dactinomycin—ocular cancer	0.00195	0.0697	CcSEcCtD
Doxorubicin—Neutropenic sepsis—Dactinomycin—ocular cancer	0.00185	0.066	CcSEcCtD
Doxorubicin—Recall phenomenon—Dactinomycin—ocular cancer	0.00185	0.066	CcSEcCtD
Doxorubicin—Venous thrombosis—Carboplatin—ocular cancer	0.0016	0.0571	CcSEcCtD
Doxorubicin—Proctitis—Dactinomycin—ocular cancer	0.00131	0.0469	CcSEcCtD
Doxorubicin—Extravasation—Carboplatin—ocular cancer	0.000989	0.0353	CcSEcCtD
Doxorubicin—Multi-organ failure—Dactinomycin—ocular cancer	0.000983	0.0351	CcSEcCtD
Doxorubicin—Phlebitis—Carboplatin—ocular cancer	0.000727	0.026	CcSEcCtD
Doxorubicin—Ascites—Dactinomycin—ocular cancer	0.000705	0.0252	CcSEcCtD
Doxorubicin—Ulcerative stomatitis—Dactinomycin—ocular cancer	0.000694	0.0248	CcSEcCtD
Doxorubicin—Myelosuppression—Dactinomycin—ocular cancer	0.000683	0.0244	CcSEcCtD
Doxorubicin—AKR1A1—eye—ocular cancer	0.000671	0.0558	CbGeAlD
Doxorubicin—AKR1A1—retina—ocular cancer	0.000665	0.0553	CbGeAlD
Doxorubicin—Febrile neutropenia—Dactinomycin—ocular cancer	0.000533	0.019	CcSEcCtD
Doxorubicin—Eruption—Dactinomycin—ocular cancer	0.000521	0.0186	CcSEcCtD
Doxorubicin—Folliculitis—Dactinomycin—ocular cancer	0.00051	0.0182	CcSEcCtD
Doxorubicin—NOS1—eye—ocular cancer	0.000508	0.0423	CbGeAlD
Doxorubicin—NDUFS2—eye—ocular cancer	0.000505	0.042	CbGeAlD
Doxorubicin—NOS1—retina—ocular cancer	0.000504	0.0419	CbGeAlD
Doxorubicin—NDUFS2—retina—ocular cancer	0.000501	0.0417	CbGeAlD
Doxorubicin—AKR1A1—lymphoid tissue—ocular cancer	0.000472	0.0393	CbGeAlD
Doxorubicin—DHCR7—retina—ocular cancer	0.00047	0.0391	CbGeAlD
Doxorubicin—NOS1—epithelium—ocular cancer	0.000465	0.0387	CbGeAlD
Doxorubicin—ABCC6—eye—ocular cancer	0.000462	0.0385	CbGeAlD
Doxorubicin—ABCC6—retina—ocular cancer	0.000458	0.0381	CbGeAlD
Doxorubicin—Hepatomegaly—Dactinomycin—ocular cancer	0.000453	0.0162	CcSEcCtD
Doxorubicin—YWHAG—eye—ocular cancer	0.000435	0.0362	CbGeAlD
Doxorubicin—YWHAG—retina—ocular cancer	0.000431	0.0359	CbGeAlD
Doxorubicin—Necrosis—Dactinomycin—ocular cancer	0.000408	0.0146	CcSEcCtD
Doxorubicin—AURKA—lymphoid tissue—ocular cancer	0.000399	0.0332	CbGeAlD
Doxorubicin—RALBP1—eye—ocular cancer	0.000393	0.0327	CbGeAlD
Doxorubicin—RALBP1—retina—ocular cancer	0.000389	0.0324	CbGeAlD
Doxorubicin—Extravasation—Dactinomycin—ocular cancer	0.000367	0.0131	CcSEcCtD
Doxorubicin—CBR1—eye—ocular cancer	0.000367	0.0305	CbGeAlD
Doxorubicin—NDUFS2—lymphoid tissue—ocular cancer	0.000356	0.0296	CbGeAlD
Doxorubicin—NOS3—epithelium—ocular cancer	0.000353	0.0294	CbGeAlD
Doxorubicin—NDUFS3—lymphoid tissue—ocular cancer	0.000351	0.0293	CbGeAlD
Doxorubicin—Hypocalcaemia—Dactinomycin—ocular cancer	0.00035	0.0125	CcSEcCtD
Doxorubicin—Ulcer—Dactinomycin—ocular cancer	0.000339	0.0121	CcSEcCtD
Doxorubicin—DHCR7—lymphoid tissue—ocular cancer	0.000334	0.0278	CbGeAlD
Doxorubicin—YWHAG—lymphoid tissue—ocular cancer	0.000306	0.0255	CbGeAlD
Doxorubicin—Infection—Carboplatin—ocular cancer	0.000306	0.0109	CcSEcCtD
Doxorubicin—Aplastic anaemia—Dactinomycin—ocular cancer	0.000301	0.0107	CcSEcCtD
Doxorubicin—NQO1—eye—ocular cancer	0.000294	0.0245	CbGeAlD
Doxorubicin—Oesophagitis—Dactinomycin—ocular cancer	0.000293	0.0105	CcSEcCtD
Doxorubicin—NQO1—retina—ocular cancer	0.000291	0.0242	CbGeAlD
Doxorubicin—Mouth ulceration—Dactinomycin—ocular cancer	0.00029	0.0103	CcSEcCtD
Doxorubicin—Sepsis—Dactinomycin—ocular cancer	0.000278	0.00993	CcSEcCtD
Doxorubicin—NOS3—lymphoid tissue—ocular cancer	0.000272	0.0227	CbGeAlD
Doxorubicin—Phlebitis—Dactinomycin—ocular cancer	0.00027	0.00964	CcSEcCtD
Doxorubicin—NQO1—epithelium—ocular cancer	0.000269	0.0224	CbGeAlD
Doxorubicin—Pain—Carboplatin—ocular cancer	0.000263	0.0094	CcSEcCtD
Doxorubicin—Hepatic failure—Dactinomycin—ocular cancer	0.000259	0.00924	CcSEcCtD
Doxorubicin—CBR1—lymphoid tissue—ocular cancer	0.000258	0.0215	CbGeAlD
Doxorubicin—Body temperature increased—Carboplatin—ocular cancer	0.000243	0.00869	CcSEcCtD
Doxorubicin—Lethargy—Dactinomycin—ocular cancer	0.000237	0.00848	CcSEcCtD
Doxorubicin—Liver function test abnormal—Dactinomycin—ocular cancer	0.000215	0.00767	CcSEcCtD
Doxorubicin—Toxic epidermal necrolysis—Dactinomycin—ocular cancer	0.000209	0.00748	CcSEcCtD
Doxorubicin—Aspartate aminotransferase increased—Dactinomycin—ocular cancer	0.000209	0.00748	CcSEcCtD
Doxorubicin—CYP1B1—eye—ocular cancer	0.000206	0.0172	CbGeAlD
Doxorubicin—Dysphagia—Dactinomycin—ocular cancer	0.000201	0.00718	CcSEcCtD
Doxorubicin—Pancytopenia—Dactinomycin—ocular cancer	0.000191	0.00682	CcSEcCtD
Doxorubicin—Neutropenia—Dactinomycin—ocular cancer	0.000188	0.00671	CcSEcCtD
Doxorubicin—ABCC10—lymphoid tissue—ocular cancer	0.000185	0.0154	CbGeAlD
Doxorubicin—Pneumonia—Dactinomycin—ocular cancer	0.00018	0.00644	CcSEcCtD
Doxorubicin—Stevens-Johnson syndrome—Dactinomycin—ocular cancer	0.000178	0.00635	CcSEcCtD
Doxorubicin—Stomatitis—Dactinomycin—ocular cancer	0.000175	0.00624	CcSEcCtD
Doxorubicin—Agranulocytosis—Dactinomycin—ocular cancer	0.000167	0.00597	CcSEcCtD
Doxorubicin—Hepatitis—Dactinomycin—ocular cancer	0.000161	0.00575	CcSEcCtD
Doxorubicin—Pharyngitis—Dactinomycin—ocular cancer	0.00016	0.0057	CcSEcCtD
Doxorubicin—Erythema multiforme—Dactinomycin—ocular cancer	0.000152	0.00543	CcSEcCtD
Doxorubicin—Flushing—Dactinomycin—ocular cancer	0.000149	0.00533	CcSEcCtD
Doxorubicin—CYP1B1—lymphoid tissue—ocular cancer	0.000145	0.0121	CbGeAlD
Doxorubicin—Chills—Dactinomycin—ocular cancer	0.000144	0.00516	CcSEcCtD
Doxorubicin—Alopecia—Dactinomycin—ocular cancer	0.000142	0.00508	CcSEcCtD
Doxorubicin—Erythema—Dactinomycin—ocular cancer	0.00014	0.005	CcSEcCtD
Doxorubicin—Ill-defined disorder—Dactinomycin—ocular cancer	0.00013	0.00464	CcSEcCtD
Doxorubicin—Anaemia—Dactinomycin—ocular cancer	0.000129	0.00462	CcSEcCtD
Doxorubicin—Malaise—Dactinomycin—ocular cancer	0.000126	0.00451	CcSEcCtD
Doxorubicin—Leukopenia—Dactinomycin—ocular cancer	0.000125	0.00448	CcSEcCtD
Doxorubicin—Myalgia—Dactinomycin—ocular cancer	0.000119	0.00426	CcSEcCtD
Doxorubicin—Discomfort—Dactinomycin—ocular cancer	0.000118	0.00421	CcSEcCtD
Doxorubicin—Oedema—Dactinomycin—ocular cancer	0.000114	0.00408	CcSEcCtD
Doxorubicin—Infection—Dactinomycin—ocular cancer	0.000114	0.00406	CcSEcCtD
Doxorubicin—Thrombocytopenia—Dactinomycin—ocular cancer	0.000112	0.004	CcSEcCtD
Doxorubicin—Anorexia—Dactinomycin—ocular cancer	0.000109	0.00389	CcSEcCtD
Doxorubicin—Musculoskeletal discomfort—Dactinomycin—ocular cancer	0.000104	0.00372	CcSEcCtD
Doxorubicin—CYP2B6—lymphoid tissue—ocular cancer	9.99e-05	0.00831	CbGeAlD
Doxorubicin—Decreased appetite—Dactinomycin—ocular cancer	9.94e-05	0.00355	CcSEcCtD
Doxorubicin—Fatigue—Dactinomycin—ocular cancer	9.86e-05	0.00352	CcSEcCtD
Doxorubicin—Pain—Dactinomycin—ocular cancer	9.78e-05	0.00349	CcSEcCtD
Doxorubicin—Feeling abnormal—Dactinomycin—ocular cancer	9.42e-05	0.00336	CcSEcCtD
Doxorubicin—Gastrointestinal pain—Dactinomycin—ocular cancer	9.35e-05	0.00334	CcSEcCtD
Doxorubicin—Abdominal pain—Dactinomycin—ocular cancer	9.04e-05	0.00323	CcSEcCtD
Doxorubicin—Body temperature increased—Dactinomycin—ocular cancer	9.04e-05	0.00323	CcSEcCtD
Doxorubicin—Hypersensitivity—Dactinomycin—ocular cancer	8.42e-05	0.00301	CcSEcCtD
Doxorubicin—Asthenia—Dactinomycin—ocular cancer	8.2e-05	0.00293	CcSEcCtD
Doxorubicin—Diarrhoea—Dactinomycin—ocular cancer	7.82e-05	0.00279	CcSEcCtD
Doxorubicin—ABCB1—retina—ocular cancer	7.51e-05	0.00625	CbGeAlD
Doxorubicin—Vomiting—Dactinomycin—ocular cancer	7.27e-05	0.0026	CcSEcCtD
Doxorubicin—Rash—Dactinomycin—ocular cancer	7.21e-05	0.00257	CcSEcCtD
Doxorubicin—ABCB1—epithelium—ocular cancer	6.93e-05	0.00577	CbGeAlD
Doxorubicin—Nausea—Dactinomycin—ocular cancer	6.79e-05	0.00243	CcSEcCtD
Doxorubicin—ABCB1—lymphoid tissue—ocular cancer	5.34e-05	0.00444	CbGeAlD
Doxorubicin—AURKA—Cell Cycle—CCND1—ocular cancer	2.02e-05	0.000334	CbGpPWpGaD
Doxorubicin—NOS3—EGF/EGFR Signaling Pathway—HRAS—ocular cancer	2.02e-05	0.000334	CbGpPWpGaD
Doxorubicin—TOP2A—Integrated Pancreatic Cancer Pathway—MYC—ocular cancer	1.98e-05	0.000328	CbGpPWpGaD
Doxorubicin—TOP2A—Integrated Pancreatic Cancer Pathway—TGFB1—ocular cancer	1.98e-05	0.000328	CbGpPWpGaD
Doxorubicin—YWHAG—Membrane Trafficking—AKT1—ocular cancer	1.97e-05	0.000327	CbGpPWpGaD
Doxorubicin—NOS3—Disease—MAML2—ocular cancer	1.97e-05	0.000326	CbGpPWpGaD
Doxorubicin—TOP2A—Cell Cycle, Mitotic—CDK2—ocular cancer	1.96e-05	0.000325	CbGpPWpGaD
Doxorubicin—ABCG2—HIF-1-alpha transcription factor network—AKT1—ocular cancer	1.96e-05	0.000324	CbGpPWpGaD
Doxorubicin—AURKA—Cell Cycle—CDKN1A—ocular cancer	1.95e-05	0.000323	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—E2F5—ocular cancer	1.95e-05	0.000323	CbGpPWpGaD
Doxorubicin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—ocular cancer	1.94e-05	0.000321	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—CDKN2B—ocular cancer	1.93e-05	0.00032	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—E2F4—ocular cancer	1.91e-05	0.000316	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—RPL39—ocular cancer	1.87e-05	0.00031	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—RBL1—ocular cancer	1.87e-05	0.00031	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—E2F3—ocular cancer	1.87e-05	0.000309	CbGpPWpGaD
Doxorubicin—AURKA—Cell Cycle—EP300—ocular cancer	1.86e-05	0.000308	CbGpPWpGaD
Doxorubicin—NOS2—Disease—HDAC1—ocular cancer	1.85e-05	0.000307	CbGpPWpGaD
Doxorubicin—TOP2A—Cell Cycle, Mitotic—CDK4—ocular cancer	1.85e-05	0.000307	CbGpPWpGaD
Doxorubicin—AURKA—Cell Cycle, Mitotic—MYC—ocular cancer	1.81e-05	0.0003	CbGpPWpGaD
Doxorubicin—CYP3A4—Tryptophan metabolism—MDM2—ocular cancer	1.8e-05	0.000298	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—PSPH—ocular cancer	1.8e-05	0.000298	CbGpPWpGaD
Doxorubicin—YWHAG—Cell Cycle, Mitotic—CDKN1B—ocular cancer	1.79e-05	0.000297	CbGpPWpGaD
Doxorubicin—NOS3—EGF/EGFR Signaling Pathway—AKT1—ocular cancer	1.78e-05	0.000295	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—E2F1—ocular cancer	1.77e-05	0.000293	CbGpPWpGaD
Doxorubicin—NQO1—Metabolism—GNA11—ocular cancer	1.76e-05	0.000292	CbGpPWpGaD
Doxorubicin—NOS1—Hemostasis—TGFB1—ocular cancer	1.76e-05	0.000291	CbGpPWpGaD
Doxorubicin—YWHAG—Cell Cycle—MDM2—ocular cancer	1.76e-05	0.000291	CbGpPWpGaD
Doxorubicin—TOP2A—Cell Cycle—CDK2—ocular cancer	1.75e-05	0.00029	CbGpPWpGaD
Doxorubicin—ABCB1—HIF-1-alpha transcription factor network—EP300—ocular cancer	1.75e-05	0.00029	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—TFDP1—ocular cancer	1.73e-05	0.000287	CbGpPWpGaD
Doxorubicin—ABCC2—NRF2 pathway—TGFB1—ocular cancer	1.72e-05	0.000284	CbGpPWpGaD
Doxorubicin—YWHAG—Cell Cycle, Mitotic—CCND1—ocular cancer	1.71e-05	0.000283	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—HDAC1—ocular cancer	1.7e-05	0.000282	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism—GNA11—ocular cancer	1.7e-05	0.000282	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—ocular cancer	1.68e-05	0.000279	CbGpPWpGaD
Doxorubicin—NOS2—Disease—CDKN2B—ocular cancer	1.66e-05	0.000275	CbGpPWpGaD
Doxorubicin—TOP2A—Cell Cycle—CDK4—ocular cancer	1.66e-05	0.000274	CbGpPWpGaD
Doxorubicin—YWHAG—Cell Cycle, Mitotic—CDKN1A—ocular cancer	1.65e-05	0.000274	CbGpPWpGaD
Doxorubicin—NQO1—Metabolism—GNAQ—ocular cancer	1.64e-05	0.000272	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—MAML2—ocular cancer	1.63e-05	0.00027	CbGpPWpGaD
Doxorubicin—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—ocular cancer	1.63e-05	0.00027	CbGpPWpGaD
Doxorubicin—AURKA—Cell Cycle—MYC—ocular cancer	1.62e-05	0.000268	CbGpPWpGaD
Doxorubicin—TOP2A—Cell Cycle, Mitotic—RB1—ocular cancer	1.61e-05	0.000267	CbGpPWpGaD
Doxorubicin—YWHAG—Cell Cycle—CDKN1B—ocular cancer	1.6e-05	0.000266	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism—GNAQ—ocular cancer	1.58e-05	0.000262	CbGpPWpGaD
Doxorubicin—XDH—Metabolism—GNA11—ocular cancer	1.58e-05	0.000262	CbGpPWpGaD
Doxorubicin—YWHAG—Cell Cycle, Mitotic—EP300—ocular cancer	1.57e-05	0.000261	CbGpPWpGaD
Doxorubicin—TOP2A—Circadian rythm related genes—TP53—ocular cancer	1.56e-05	0.000259	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—E2F1—ocular cancer	1.55e-05	0.000256	CbGpPWpGaD
Doxorubicin—YWHAG—Cell Cycle—CCND1—ocular cancer	1.53e-05	0.000253	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—CDKN2B—ocular cancer	1.53e-05	0.000253	CbGpPWpGaD
Doxorubicin—NOS2—Hemostasis—EP300—ocular cancer	1.53e-05	0.000253	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—TFDP1—ocular cancer	1.51e-05	0.00025	CbGpPWpGaD
Doxorubicin—YWHAG—Cell Cycle—CDKN1A—ocular cancer	1.48e-05	0.000245	CbGpPWpGaD
Doxorubicin—XDH—Metabolism—GNAQ—ocular cancer	1.47e-05	0.000244	CbGpPWpGaD
Doxorubicin—NOS1—Hemostasis—TP53—ocular cancer	1.45e-05	0.00024	CbGpPWpGaD
Doxorubicin—TOP2A—Cell Cycle—RB1—ocular cancer	1.44e-05	0.000239	CbGpPWpGaD
Doxorubicin—NOS3—Disease—HDAC1—ocular cancer	1.44e-05	0.000238	CbGpPWpGaD
Doxorubicin—NOS3—Metabolism—GNA11—ocular cancer	1.44e-05	0.000238	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—GNA11—ocular cancer	1.42e-05	0.000236	CbGpPWpGaD
Doxorubicin—YWHAG—Cell Cycle—EP300—ocular cancer	1.41e-05	0.000233	CbGpPWpGaD
Doxorubicin—NOS1—Hemostasis—HRAS—ocular cancer	1.38e-05	0.000229	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—MAML2—ocular cancer	1.38e-05	0.000228	CbGpPWpGaD
Doxorubicin—TOP2A—Integrated Pancreatic Cancer Pathway—AKT1—ocular cancer	1.37e-05	0.000228	CbGpPWpGaD
Doxorubicin—YWHAG—Cell Cycle, Mitotic—MYC—ocular cancer	1.37e-05	0.000227	CbGpPWpGaD
Doxorubicin—NDUFS3—Metabolism—EP300—ocular cancer	1.35e-05	0.000224	CbGpPWpGaD
Doxorubicin—NDUFS7—Metabolism—EP300—ocular cancer	1.35e-05	0.000224	CbGpPWpGaD
Doxorubicin—NOS3—Metabolism—GNAQ—ocular cancer	1.34e-05	0.000221	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—CDK2—ocular cancer	1.33e-05	0.000221	CbGpPWpGaD
Doxorubicin—AURKA—Cell Cycle—TP53—ocular cancer	1.33e-05	0.00022	CbGpPWpGaD
Doxorubicin—NOS2—Hemostasis—TGFB1—ocular cancer	1.33e-05	0.00022	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—PSPH—ocular cancer	1.32e-05	0.000219	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—GNAQ—ocular cancer	1.32e-05	0.000219	CbGpPWpGaD
Doxorubicin—ABCB1—Allograft Rejection—TGFB1—ocular cancer	1.32e-05	0.000219	CbGpPWpGaD
Doxorubicin—NOS3—Disease—CDKN2B—ocular cancer	1.29e-05	0.000214	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism of lipids and lipoproteins—EP300—ocular cancer	1.28e-05	0.000212	CbGpPWpGaD
Doxorubicin—NDUFS2—Metabolism—EP300—ocular cancer	1.27e-05	0.000211	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—ocular cancer	1.26e-05	0.000209	CbGpPWpGaD
Doxorubicin—TOP2A—Cell Cycle, Mitotic—CDKN1B—ocular cancer	1.25e-05	0.000208	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—PSPH—ocular cancer	1.25e-05	0.000207	CbGpPWpGaD
Doxorubicin—TOP2A—Cell Cycle—MDM2—ocular cancer	1.23e-05	0.000203	CbGpPWpGaD
Doxorubicin—YWHAG—Cell Cycle—MYC—ocular cancer	1.23e-05	0.000203	CbGpPWpGaD
Doxorubicin—NOS1—Hemostasis—AKT1—ocular cancer	1.22e-05	0.000203	CbGpPWpGaD
Doxorubicin—NOS1—Disease—MDM2—ocular cancer	1.22e-05	0.000202	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—GNA11—ocular cancer	1.2e-05	0.000199	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—MAML2—ocular cancer	1.2e-05	0.000199	CbGpPWpGaD
Doxorubicin—TOP2A—Cell Cycle, Mitotic—CCND1—ocular cancer	1.2e-05	0.000198	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—HDAC1—ocular cancer	1.19e-05	0.000198	CbGpPWpGaD
Doxorubicin—NOS3—Hemostasis—EP300—ocular cancer	1.18e-05	0.000196	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—GNA11—ocular cancer	1.17e-05	0.000193	CbGpPWpGaD
Doxorubicin—TOP2A—Cell Cycle, Mitotic—CDKN1A—ocular cancer	1.16e-05	0.000192	CbGpPWpGaD
Doxorubicin—TOP2A—Cell Cycle—CDKN1B—ocular cancer	1.12e-05	0.000186	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—GNA11—ocular cancer	1.12e-05	0.000185	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—GNAQ—ocular cancer	1.12e-05	0.000185	CbGpPWpGaD
Doxorubicin—NOS1—Disease—CDKN1B—ocular cancer	1.12e-05	0.000185	CbGpPWpGaD
Doxorubicin—TOP2A—Cell Cycle, Mitotic—EP300—ocular cancer	1.1e-05	0.000182	CbGpPWpGaD
Doxorubicin—NOS2—Hemostasis—TP53—ocular cancer	1.09e-05	0.000181	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—GNAQ—ocular cancer	1.08e-05	0.00018	CbGpPWpGaD
Doxorubicin—DHCR7—Metabolism—EP300—ocular cancer	1.08e-05	0.000179	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—MDM2—ocular cancer	1.07e-05	0.000177	CbGpPWpGaD
Doxorubicin—TOP2A—Cell Cycle—CCND1—ocular cancer	1.07e-05	0.000177	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—CDKN2B—ocular cancer	1.07e-05	0.000177	CbGpPWpGaD
Doxorubicin—ABCB1—HIF-1-alpha transcription factor network—AKT1—ocular cancer	1.06e-05	0.000175	CbGpPWpGaD
Doxorubicin—NOS2—Hemostasis—HRAS—ocular cancer	1.04e-05	0.000173	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—GNAQ—ocular cancer	1.04e-05	0.000172	CbGpPWpGaD
Doxorubicin—TOP2A—Cell Cycle—CDKN1A—ocular cancer	1.03e-05	0.000171	CbGpPWpGaD
Doxorubicin—NOS3—Hemostasis—TGFB1—ocular cancer	1.03e-05	0.000171	CbGpPWpGaD
Doxorubicin—NOS1—Disease—CDKN1A—ocular cancer	1.03e-05	0.000171	CbGpPWpGaD
Doxorubicin—CBR1—Metabolism—EP300—ocular cancer	1.01e-05	0.000167	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—HDAC1—ocular cancer	1.01e-05	0.000167	CbGpPWpGaD
Doxorubicin—YWHAG—Cell Cycle—TP53—ocular cancer	1.01e-05	0.000167	CbGpPWpGaD
Doxorubicin—TOP2A—Cell Cycle—EP300—ocular cancer	9.84e-06	0.000163	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—E2F1—ocular cancer	9.81e-06	0.000163	CbGpPWpGaD
Doxorubicin—NOS1—Disease—EP300—ocular cancer	9.79e-06	0.000162	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—CDKN1B—ocular cancer	9.77e-06	0.000162	CbGpPWpGaD
Doxorubicin—TOP2A—Cell Cycle, Mitotic—MYC—ocular cancer	9.59e-06	0.000159	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—ocular cancer	9.34e-06	0.000155	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—CCND1—ocular cancer	9.32e-06	0.000154	CbGpPWpGaD
Doxorubicin—NOS2—Hemostasis—AKT1—ocular cancer	9.22e-06	0.000153	CbGpPWpGaD
Doxorubicin—NOS2—Disease—MDM2—ocular cancer	9.21e-06	0.000153	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—CDKN2B—ocular cancer	9.03e-06	0.00015	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—CDKN1A—ocular cancer	9.02e-06	0.000149	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—HDAC1—ocular cancer	8.77e-06	0.000145	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—GNA11—ocular cancer	8.76e-06	0.000145	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism of lipids and lipoproteins—EP300—ocular cancer	8.75e-06	0.000145	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—EP300—ocular cancer	8.58e-06	0.000142	CbGpPWpGaD
Doxorubicin—TOP2A—Cell Cycle—MYC—ocular cancer	8.58e-06	0.000142	CbGpPWpGaD
Doxorubicin—NOS1—Disease—MYC—ocular cancer	8.54e-06	0.000141	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—ocular cancer	8.53e-06	0.000141	CbGpPWpGaD
Doxorubicin—NOS1—Disease—TGFB1—ocular cancer	8.51e-06	0.000141	CbGpPWpGaD
Doxorubicin—NOS3—Hemostasis—TP53—ocular cancer	8.48e-06	0.00014	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—GNA11—ocular cancer	8.47e-06	0.00014	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—MDM2—ocular cancer	8.47e-06	0.00014	CbGpPWpGaD
Doxorubicin—NOS2—Disease—CDKN1B—ocular cancer	8.41e-06	0.000139	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism of lipids and lipoproteins—EP300—ocular cancer	8.39e-06	0.000139	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—E2F1—ocular cancer	8.29e-06	0.000137	CbGpPWpGaD
Doxorubicin—NDUFS3—Metabolism—AKT1—ocular cancer	8.18e-06	0.000136	CbGpPWpGaD
Doxorubicin—NDUFS7—Metabolism—AKT1—ocular cancer	8.18e-06	0.000136	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—PSPH—ocular cancer	8.16e-06	0.000135	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—GNAQ—ocular cancer	8.15e-06	0.000135	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—ocular cancer	8.14e-06	0.000135	CbGpPWpGaD
Doxorubicin—NOS3—Hemostasis—HRAS—ocular cancer	8.11e-06	0.000134	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—GNAQ—ocular cancer	7.88e-06	0.000131	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—ocular cancer	7.87e-06	0.00013	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—CDKN2B—ocular cancer	7.86e-06	0.00013	CbGpPWpGaD
Doxorubicin—NOS2—Disease—CDKN1A—ocular cancer	7.76e-06	0.000129	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—CDKN1B—ocular cancer	7.73e-06	0.000128	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—GNA11—ocular cancer	7.71e-06	0.000128	CbGpPWpGaD
Doxorubicin—NDUFS2—Metabolism—AKT1—ocular cancer	7.69e-06	0.000127	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—ocular cancer	7.49e-06	0.000124	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—MYC—ocular cancer	7.48e-06	0.000124	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—TGFB1—ocular cancer	7.46e-06	0.000124	CbGpPWpGaD
Doxorubicin—NOS2—Disease—EP300—ocular cancer	7.39e-06	0.000122	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—GNAQ—ocular cancer	7.17e-06	0.000119	CbGpPWpGaD
Doxorubicin—NOS3—Hemostasis—AKT1—ocular cancer	7.16e-06	0.000119	CbGpPWpGaD
Doxorubicin—NOS3—Disease—MDM2—ocular cancer	7.15e-06	0.000119	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—CDKN1A—ocular cancer	7.14e-06	0.000118	CbGpPWpGaD
Doxorubicin—TOP2A—Cell Cycle—TP53—ocular cancer	7.05e-06	0.000117	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—EP300—ocular cancer	6.79e-06	0.000112	CbGpPWpGaD
Doxorubicin—NOS1—Disease—HRAS—ocular cancer	6.7e-06	0.000111	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism of lipids and lipoproteins—EP300—ocular cancer	6.57e-06	0.000109	CbGpPWpGaD
Doxorubicin—DHCR7—Metabolism—AKT1—ocular cancer	6.54e-06	0.000108	CbGpPWpGaD
Doxorubicin—NOS3—Disease—CDKN1B—ocular cancer	6.53e-06	0.000108	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—ocular cancer	6.53e-06	0.000108	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—ocular cancer	6.51e-06	0.000108	CbGpPWpGaD
Doxorubicin—NOS2—Disease—MYC—ocular cancer	6.44e-06	0.000107	CbGpPWpGaD
Doxorubicin—NOS2—Disease—TGFB1—ocular cancer	6.42e-06	0.000106	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism of lipids and lipoproteins—EP300—ocular cancer	6.36e-06	0.000105	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—TP53—ocular cancer	6.14e-06	0.000102	CbGpPWpGaD
Doxorubicin—CBR1—Metabolism—AKT1—ocular cancer	6.1e-06	0.000101	CbGpPWpGaD
Doxorubicin—NOS3—Disease—CDKN1A—ocular cancer	6.03e-06	9.99e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—MDM2—ocular cancer	5.93e-06	9.82e-05	CbGpPWpGaD
Doxorubicin—NOS1—Disease—AKT1—ocular cancer	5.92e-06	9.81e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—MYC—ocular cancer	5.92e-06	9.8e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—TGFB1—ocular cancer	5.9e-06	9.78e-05	CbGpPWpGaD
Doxorubicin—NQO1—Metabolism—EP300—ocular cancer	5.89e-06	9.76e-05	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—HRAS—ocular cancer	5.87e-06	9.73e-05	CbGpPWpGaD
Doxorubicin—NOS3—Disease—EP300—ocular cancer	5.74e-06	9.5e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism—EP300—ocular cancer	5.69e-06	9.42e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—GNA11—ocular cancer	5.65e-06	9.36e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—CDKN1B—ocular cancer	5.41e-06	8.97e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—ocular cancer	5.36e-06	8.88e-05	CbGpPWpGaD
Doxorubicin—XDH—Metabolism—EP300—ocular cancer	5.29e-06	8.76e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—GNAQ—ocular cancer	5.25e-06	8.71e-05	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—AKT1—ocular cancer	5.18e-06	8.59e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—CCND1—ocular cancer	5.16e-06	8.56e-05	CbGpPWpGaD
Doxorubicin—NOS2—Disease—HRAS—ocular cancer	5.06e-06	8.38e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—MDM2—ocular cancer	5.01e-06	8.3e-05	CbGpPWpGaD
Doxorubicin—NOS3—Disease—MYC—ocular cancer	5e-06	8.28e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—CDKN1A—ocular cancer	5e-06	8.28e-05	CbGpPWpGaD
Doxorubicin—NOS3—Disease—TGFB1—ocular cancer	4.99e-06	8.26e-05	CbGpPWpGaD
Doxorubicin—NOS3—Metabolism—EP300—ocular cancer	4.8e-06	7.96e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—EP300—ocular cancer	4.75e-06	7.88e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—HRAS—ocular cancer	4.65e-06	7.7e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—CDKN1B—ocular cancer	4.57e-06	7.58e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—ocular cancer	4.53e-06	7.5e-05	CbGpPWpGaD
Doxorubicin—NOS2—Disease—AKT1—ocular cancer	4.46e-06	7.4e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—CCND1—ocular cancer	4.36e-06	7.23e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—MDM2—ocular cancer	4.36e-06	7.22e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—CDKN1A—ocular cancer	4.22e-06	6.99e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—GNA11—ocular cancer	4.17e-06	6.91e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—MYC—ocular cancer	4.14e-06	6.86e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—TGFB1—ocular cancer	4.13e-06	6.85e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—AKT1—ocular cancer	4.1e-06	6.8e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—EP300—ocular cancer	4.02e-06	6.66e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—CDKN1B—ocular cancer	3.98e-06	6.6e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—GNA11—ocular cancer	3.93e-06	6.51e-05	CbGpPWpGaD
Doxorubicin—NOS3—Disease—HRAS—ocular cancer	3.93e-06	6.5e-05	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—EP300—ocular cancer	3.9e-06	6.46e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—GNAQ—ocular cancer	3.88e-06	6.42e-05	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—EP300—ocular cancer	3.74e-06	6.19e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—CDKN1A—ocular cancer	3.67e-06	6.09e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—GNAQ—ocular cancer	3.65e-06	6.05e-05	CbGpPWpGaD
Doxorubicin—NQO1—Metabolism—AKT1—ocular cancer	3.56e-06	5.9e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—MYC—ocular cancer	3.5e-06	5.8e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—EP300—ocular cancer	3.5e-06	5.79e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—TGFB1—ocular cancer	3.49e-06	5.79e-05	CbGpPWpGaD
Doxorubicin—NOS3—Disease—AKT1—ocular cancer	3.47e-06	5.74e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Metabolism—AKT1—ocular cancer	3.44e-06	5.69e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—TP53—ocular cancer	3.4e-06	5.64e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—HRAS—ocular cancer	3.25e-06	5.39e-05	CbGpPWpGaD
Doxorubicin—XDH—Metabolism—AKT1—ocular cancer	3.19e-06	5.29e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—MYC—ocular cancer	3.05e-06	5.05e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—TGFB1—ocular cancer	3.04e-06	5.03e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—EP300—ocular cancer	2.93e-06	4.85e-05	CbGpPWpGaD
Doxorubicin—NOS3—Metabolism—AKT1—ocular cancer	2.9e-06	4.81e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—TP53—ocular cancer	2.87e-06	4.76e-05	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—AKT1—ocular cancer	2.87e-06	4.76e-05	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—EP300—ocular cancer	2.83e-06	4.69e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—HRAS—ocular cancer	2.75e-06	4.55e-05	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—EP300—ocular cancer	2.58e-06	4.27e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—GNA11—ocular cancer	2.57e-06	4.26e-05	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—AKT1—ocular cancer	2.43e-06	4.02e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—HRAS—ocular cancer	2.39e-06	3.96e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—GNAQ—ocular cancer	2.39e-06	3.96e-05	CbGpPWpGaD
Doxorubicin—ABCB11—Metabolism—AKT1—ocular cancer	2.35e-06	3.9e-05	CbGpPWpGaD
Doxorubicin—ABCC3—Metabolism—AKT1—ocular cancer	2.26e-06	3.74e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—AKT1—ocular cancer	2.11e-06	3.5e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—EP300—ocular cancer	1.89e-06	3.13e-05	CbGpPWpGaD
Doxorubicin—ABCC1—Metabolism—AKT1—ocular cancer	1.77e-06	2.93e-05	CbGpPWpGaD
Doxorubicin—CYP1B1—Metabolism—AKT1—ocular cancer	1.71e-06	2.83e-05	CbGpPWpGaD
Doxorubicin—ABCG2—Metabolism—AKT1—ocular cancer	1.56e-06	2.58e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—EP300—ocular cancer	1.39e-06	2.31e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—EP300—ocular cancer	1.31e-06	2.17e-05	CbGpPWpGaD
Doxorubicin—CYP2B6—Metabolism—AKT1—ocular cancer	1.14e-06	1.89e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—EP300—ocular cancer	8.58e-07	1.42e-05	CbGpPWpGaD
Doxorubicin—ABCB1—Metabolism—AKT1—ocular cancer	8.42e-07	1.39e-05	CbGpPWpGaD
Doxorubicin—CYP2D6—Metabolism—AKT1—ocular cancer	7.93e-07	1.31e-05	CbGpPWpGaD
Doxorubicin—CYP3A4—Metabolism—AKT1—ocular cancer	5.19e-07	8.59e-06	CbGpPWpGaD
